CAMP4 Therapeutics Corporation (CAMP) vs MacroGenics, Inc. (MGNX)
A side-by-side comparison of CAMP4 Therapeutics Corporation and MacroGenics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAMP
CAMP4 Therapeutics Corporation
$3.83HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
MGNX
MacroGenics, Inc.
$3.63HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
Total return — CAMP vs MGNX
growth of $100 · dividends reinvested · last 2yCAMP -62.6% (-38.8%/yr)MGNX +0.8% (+0.4%/yr)MGNX compounded faster over this window
CAMP MGNX
CAMP vs MGNX: by the numbers
- •CAMP is the larger company ($240M vs $230M market cap).
- •Both run net losses; MGNX's is the smaller (-8.70% vs -2543.74% net margin).
- •MGNX grew revenue faster over the past five years (7.33% vs -57.68% CAGR).
Metrics side by side
Valuation
| Metric | CAMP | MGNX |
|---|---|---|
| P/S ratio | 57.01 | 1.37 |
| P/B ratio | N/A | 5.37 |
Profitability
| Metric | CAMP | MGNX |
|---|---|---|
| Gross margin | 53.14% | 71.12% |
| Operating margin | -1488.31% | -48.72% |
| Net margin | -2543.74% | -8.70% |
| ROE | N/A | -34.04% |
| ROIC | -69.76% | -16.87% |
Growth (annualized)
| Metric | CAMP | MGNX |
|---|---|---|
| Revenue CAGR (5Y) | -57.68% | 7.33% |
| Total return CAGR (5Y) | N/A | -28.42% |
Frequently asked
- Which has grown faster, CAMP or MGNX?
- Over the past five years, MGNX grew revenue faster — CAMP at a -57.68% CAGR versus MGNX at 7.33%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.